ClinVar Miner

Submissions for variant NM_016169.4(SUFU):c.911-8C>A

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV002378690 SCV002684206 likely pathogenic Hereditary cancer-predisposing syndrome 2019-05-03 criteria provided, single submitter clinical testing The c.911-8C>A intronic variant results from a C to A substitution 8 nucleotides upstream from coding exon 8 in the SUFU gene. This nucleotide position is poorly conserved in available vertebrate species, however adenine is not an observed substitution. Using the BDGP and ESEfinder splice site prediction tools, this alteration is predicted to weaken the efficiency of the native splice acceptor site. RNA studies have demonstrated this alteration results in abnormal splicing in the set of samples tested (Ambry internal data). SUFU c.1022+1G>A is an alteration at the splice donor site of exon 8 and results in the same aberrant out-of-frame transcript lacking exon 8. This donor site alteration was identified in two individuals from the same family with features of Gorlin syndrome (Pastorino L et al. Am. J. Med. Genet. A, 2009 Jul;149A:1539-43). Based on the majority of available evidence to date, this variant is likely to be pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.